Genentech

LUCENTIS - Cost

Last Updated: April 1st, 2024

HCPCS:

J2778

HCPCS Code Descriptor:

Injection, ranibizumab, 0.1 mg

Medicare Payment Limit:

The LUCENTIS Medicare Payment Limit is $173.378

Average Sale Price:

LUCENTIS ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The LUCENTIS Medicare Co-insurance percentage is 20%. LUCENTIS's Medicare Co-insurance amount is $34.68 per HCPCS unit.

APC Code:

The Lucentis: APC Code is: 9233

APC Payment Limit:

The APC Payment Limit for LUCENTIS is available. Login to view.

Lucentis Cost Information:

Lucentis (ranibizumab) is aligned to the J code J2778 which became effective on January 1st, 2008. During it’s time on the market, the WAC and AWP list prices for Lucentis have remained stable. In early 2022, lower priced biosimilar alternatives began competing with Lucentis. Facing biosimilar competition, the ASP for Lucentis began to steadily decline. From October 2021 to January 2024 the average sales price for Lucentis dropped by almost 50%. As of January 2024, there are currently two biosimilar drugs for Lucentis: Byooviz and Cimerli.

ACCESS PRICING AND MORE BY REGISTERING

Lucentis’s wholesale acquisition cost (WAC) information was last updated on:
April 23, 2018
Lucentis’s average wholesale price (AWP) information was last updated on:
April 23, 2018